KI-SciLifeLab postdoc program: previously awarded projects

SFO SciLifeLab at KI has funded grants for recruitment of postdocs to collaborative projects with clinical translational focus. Below are the projects awarded in 2022 and 2024.

Evaluation of Tumor DNA Copy Number Variations as a Predictive Factor for Treatment Selection in Hormone-Sensitive Breast Cancer

Main applicant: Theodoros Foukakis, OnkPat
Co-applicant: Nicola Crosetto
Postdoc: Konstantinos Georgiadis

MALDI-MS to Improve Diagnostic and Prognostic Biomarkers in Parkinsonism

Main applicant: Per Svenningsson, CNS
Postdoc: Ellen Appleton, followed by Daulet Sharipov

Dissecting the Abscopal Effect of Precision Radiotherapy in Non-Irradiated Immunotherapy-Resistant Melanoma Metastases Using Multiplex In Situ Genomics and T-Cell Receptor Repertoire Sequencing

Main applicant: Hildur Helgadottir, OnkPat
Postdoc: Muyi Yang

Molecular Phenotyping of Reduced Brain Metabolism in Patients with ALS/FTD

Main applicant: Sebastian Lewandowski, CNS
Postdoc: Aditya Singh

Studies of mRNA Translation in Endocrine Treatment-Resistant Breast Cancer

Main applicant: Ola Larsson, OnkPat
Co-applicant: Johan Hartman, OnkPat
Postdoc: Krzysztof Szkop

Neoantigen-Based Treatment Strategies for SF3B1-Mutated Myelodysplastic Syndromes

Main applicant: Janne Lehtiö, OnkPat
Co-applicant: Eva Hellström Lindberg, MedH
Postdoc: Alexandra Argyriou

Mapping Immune Cell Clones in Breast Cancer During Treatment

Main applicant: Camilla Engblom, MedS
Co-applicant: Johan Hartman, OnkPat
Postdoc: Sonia Corral Leal

Investigation of Drug-Phage Synergy for MDR Bacteria

Main applicant: Andrea Fossati, MTC
Co-applicant: Christian Giske, LabMed
Postdoc: David Parker

A Systems-Level View of Acute Myeloid Leukemia Using Epigenetic Plasma Profiling

Main applicant: Simon Elsässer, MBB
Co-applicant: Sören Lehmann, MedH
Postdoc: Luzeena Raja Arul

Improving Nelarabine Treatment in T-ALL through the Identification of Biomarkers and Therapeutic Agents

Main applicant: Sean Rudd, OnkPat
Co-applicant: Nikolas Herold, KBH
Postdoc: Radosveta Gencheva